Published in Ann Surg on March 01, 1979
Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance. Ann Surg (1980) 1.85
Temporary incomplete ischemia of the legs induced by aortic clamping in man: effects on central hemodynamics and skeletal muscle metabolism by adrenergic block. Ann Surg (1981) 0.78
Temporary incomplete ischemia of the legs caused by aortic clamping in man: improvement of skeletal muscle metabolism by low molecular dextran. Ann Surg (1981) 0.77
The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry (1968) 9.00
Body metabolism during general anesthesia without superimposed surgical stress. Anesth Analg (1972) 1.56
Creatine metabolism in skeletal muscle. I. Creatine movement across muscle membranes. J Biol Chem (1966) 1.23
The effect of moderate and marked hypercapnia upon the energy state and upon the cytoplasmic NADH-NAD+ ratio of the rat brain. J Neurochem (1972) 1.15
Lactate metabolism. Anesthesiology (1975) 1.10
Prevention of hypotensive and renal complications of aortic surgery using balanced salt solution: thirteen-year experience with 670 cases. Ann Surg (1968) 1.07
The effect of hypercapnic acidosis upon some glycolytic and Krebs cycle-associated intermediates in the rat brain. J Neurochem (1972) 1.05
Effects of hypothermia on systemic and organ system metabolism and function. J Surg Res (1976) 0.99
Hypothermia and tourniquet ischemia. Plast Reconstr Surg Transplant Bull (1962) 0.98
Human skeletal muscle energy metabolism during and after complete tourniquet ischemia. Ann Surg (1975) 0.98
Patterns of changes in brain carbohydrate metabolites, amino acids and organic phosphates at increased carbon dioxide tensions. J Neurochem (1974) 0.96
Physiological and technical factors in the surgical treatment of abdominal aortic aneurysms. Surgery (1967) 0.88
Brain metabolism in the critically ill. Crit Care Med (1990) 0.82
Eschaemia during arterial reconstructive surgery. Biochemical changes as reflected in popliteal vein samples. Scand J Thorac Cardiovasc Surg (1977) 0.80
Postischemic hyperemia and metabolic changes after long-lasting blood flow interruption of a dog extremity. Vasc Surg (1973) 0.80
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
The statistical inevitability of stability-diversity relationships in community ecology. Am Nat (1998) 5.66
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum (2006) 5.20
Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol (1972) 4.94
The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med (1973) 4.74
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10
The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity (1996) 4.02
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med (2001) 3.69
Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte. Cell (1977) 3.23
Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev (1991) 3.08
T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level. Proc Natl Acad Sci U S A (1980) 3.08
Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect Immun (1993) 2.83
Frequencies of mitogen-reactive B cells in the mouse. I. Distribution in different lymphoid organs from different inbred strains of mice at different ages. J Exp Med (1977) 2.68
Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors. Eur J Immunol (1979) 2.59
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Activation of B lymphocytes by locally concentrated concanavalin A. Eur J Immunol (1972) 2.41
Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol (1998) 2.38
Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action. Eur J Immunol (1974) 2.33
Synthesis, surface deposition and secretion of immunoglobulin M in bone marrow-derived lymphocytes before and after mitogenic stimulation. Transplant Rev (1973) 2.14
Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood (2001) 2.13
Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors. Eur J Immunol (1979) 2.10
High mobility group 1 B-box mediates activation of human endothelium. J Intern Med (2003) 2.00
The bidirectional cavopulmonary shunt. J Thorac Cardiovasc Surg (1990) 1.89
Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun (1995) 1.88
A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J Exp Med (1996) 1.86
Antigen-specific T-helper cells stimulate H-2-compatible and H-2-incompatible B-cell blasts polyclonally. J Exp Med (1980) 1.85
Ribavirin treatment for chronic hepatitis C. Lancet (1991) 1.84
Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. Clin Infect Dis (1998) 1.83
B lymphocytes can be stimulated by concanavalin A in the presence of humoral factors released by T cells. Eur J Immunol (1972) 1.81
The kinectics of proliferation and maturation of mitogen-activated bone marrow-derived lymphocytes. Eur J Immunol (1974) 1.81
Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur J Immunol (1998) 1.80
Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol (2001) 1.80
H-2-unrestricted polyclonal maturation without replication of small B cells induced by antigen-activated T cell help factors. Eur J Immunol (1980) 1.77
Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures. J Immunol (1972) 1.73
IgM in bone marrow-derived lymphocytes. Synthesis, surface deposition, turnover and carbohydrate composition in unstimulated mouse B cells. Eur J Immunol (1974) 1.71
Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis (1995) 1.71
MHC interaction and T cell recognition of carbohydrates and glycopeptides. J Immunol (1992) 1.71
Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST). Br J Cancer (2007) 1.68
Problem drug use in a central London general practice. BMJ (1992) 1.67
A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam. J Pharmacokinet Biopharm (1991) 1.64
Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer (1993) 1.64
Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis (1995) 1.64
Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci U S A (1987) 1.63
RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat Cell Biol (2001) 1.63
IgM-producing tumors in the BALB-c mouse: a model for B-cell maturation. J Exp Med (1974) 1.61
Mutations affecting either generation or survival of cells influence the pool size of mature B cells. Immunity (1999) 1.61
Cloning of murine transformed cell lines in suspension culture with efficiencies near 100%. Exp Cell Res (1978) 1.55
An Arabidopsis thaliana protein homologous to cyanobacterial high-light-inducible proteins. Plant Mol Biol (2000) 1.54
The renal lesions of toxaemia and abruptio placentae studied by light and electron microscopy. J Obstet Gynaecol Br Commonw (1972) 1.53
The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg (1990) 1.53
The switch from IgM to IgG secretion in single mitogen-stimulated B-cell clones. J Exp Med (1978) 1.52
Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol (1987) 1.52
Requirement for adherent cells in the primary and secondary immune response in vitro. Eur J Immunol (1972) 1.51
Change in epidemiology and preventive medicine. Proc R Soc Med (1965) 1.49
Analysis of the anti-p53 antibody response in cancer patients. Cancer Res (1993) 1.49
A glycyl radical site in the crystal structure of a class III ribonucleotide reductase. Science (1999) 1.49
Sex differences in emigration and mortality affect optimal management of deer populations. Nature (2002) 1.49
Plants lacking the main light-harvesting complex retain photosystem II macro-organization. Nature (2003) 1.48
Lipopolysaccharides can convert heterologous red cells into thymus-independent antigens. Cell Immunol (1972) 1.48
Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer (2003) 1.44
Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes. Eur J Immunol (1990) 1.44
Continuous growth of mitogen-reactive B lymphocytes. Scand J Immunol (1975) 1.43
Death in notified cases of tuberculosis in Edinburgh: 1983-1992. Respir Med (1995) 1.42
The role of T cell growth stimulating factors in T cell triggering. Immunol Rev (1980) 1.42
Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med (2000) 1.41
Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer (2007) 1.41
Maturation of mitogen-activated bone marrow-derived lymphocytes in the absence of proliferation. Eur J Immunol (1974) 1.40
IgM in bone marrow-derived lymphocytes. Changes in synthesis, turnover and secretion, and in numbers of molecules on the surface of B cells after mitogenic stimulation. Eur J Immunol (1974) 1.39
Amino acid sequence of a (32P) phosphopeptide from pig liver pyruvate kinase phosphorylated by cyclic 3',5'-AMP-stimulated protein kinase and gamma-(32P)ATP. Biochem Biophys Res Commun (1974) 1.39
Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J Infect Dis (2000) 1.38
Continuing education: the 1998 Survey of the Royal Australasian College of Dental Surgeons. Aust Dent J (2001) 1.37
Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells. Immunol Rev (2000) 1.37
Proliferative glomerulonephritis and exposure to organic solvents. Nephron (1985) 1.33
Ontogeny of murine B lymphocytes: development of Ig synthesis and of reactivities to mitogens and to anti-Ig-antibodies. Cold Spring Harb Symp Quant Biol (1977) 1.31
Positive and negative selection events during B lymphopoiesis. Curr Opin Immunol (1995) 1.31
Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. Immunology (1995) 1.30
Regional cerebral blood flow in the rat measured by the tissue sampling technique; a critical evaluation using four indicators C14-antipyrine, C14-ethanol H3-water and xenon. Acta Physiol Scand (1974) 1.30
Primary closure or secondary granulation after excision of pilonidal sinus? Acta Chir Scand (1990) 1.30
Mitogen-activated B-cell blasts reactive to more than one mitogen. J Exp Med (1979) 1.28
Computerized assessment of production of multiple human cytokines at the single-cell level using image analysis. J Leukoc Biol (1996) 1.27
Mitogen-induced lymphocyte-mediated cytotoxicity in vitro: effect of mitogens selectively activating T or B cells. Eur J Immunol (1972) 1.26
Factors controlling the B-cell cycle. Annu Rev Immunol (1986) 1.26
Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J Thromb Haemost (2008) 1.26
Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis (1998) 1.26
Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J Infect Dis (1990) 1.25
Evidence for superantigen involvement in severe group a streptococcal tissue infections. J Infect Dis (2001) 1.23
Sickness absence in the civil service. Proc R Soc Med (1972) 1.23
Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum. Pharm Res (1993) 1.23
Influenza A in immunocompromised patients. Clin Infect Dis (1993) 1.22
Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis (1996) 1.22
Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg (1990) 1.22
Rectal premedication in children. Use of diazepam, morphine and hyoscine. Anaesthesia (1981) 1.21
Induction of immunoglobulin M synthesis and secretion in bone-marrow-derived lymphocytes by locally concentrated concanavalin A. Proc Natl Acad Sci U S A (1973) 1.21
Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun (1994) 1.21